CA2002472A1 - Liquid oral formulation - Google Patents

Liquid oral formulation

Info

Publication number
CA2002472A1
CA2002472A1 CA2002472A CA2002472A CA2002472A1 CA 2002472 A1 CA2002472 A1 CA 2002472A1 CA 2002472 A CA2002472 A CA 2002472A CA 2002472 A CA2002472 A CA 2002472A CA 2002472 A1 CA2002472 A1 CA 2002472A1
Authority
CA
Canada
Prior art keywords
oral formulation
liquid oral
formulation
diclofenac
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2002472A
Other languages
French (fr)
Other versions
CA2002472C (en
Inventor
Heidi Affolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of CA2002472A1 publication Critical patent/CA2002472A1/en
Application granted granted Critical
Publication of CA2002472C publication Critical patent/CA2002472C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to an aqueous oral pharmaceutical formulation of diclofenac, which can be used for treating pain and inflammatory processes, and also to the preparation of such a formulation.
CA002002472A 1988-11-10 1989-11-08 Liquid oral formulation Expired - Lifetime CA2002472C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4167/88-7 1988-11-10
CH416788 1988-11-10

Publications (2)

Publication Number Publication Date
CA2002472A1 true CA2002472A1 (en) 1990-05-10
CA2002472C CA2002472C (en) 2000-05-30

Family

ID=4271057

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002002472A Expired - Lifetime CA2002472C (en) 1988-11-10 1989-11-08 Liquid oral formulation

Country Status (16)

Country Link
EP (1) EP0373103B1 (en)
JP (1) JP2894744B2 (en)
KR (1) KR0152983B1 (en)
AT (1) ATE87476T1 (en)
AU (1) AU624190B2 (en)
CA (1) CA2002472C (en)
DE (1) DE58903964D1 (en)
DK (1) DK175752B1 (en)
ES (1) ES2054089T3 (en)
GR (1) GR3007995T3 (en)
IE (1) IE63482B1 (en)
IL (1) IL92190A (en)
NZ (1) NZ231320A (en)
PT (1) PT92228B (en)
SA (1) SA90100152B1 (en)
ZA (1) ZA898554B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080802B2 (en) 2011-10-31 2018-09-25 Novartis Ag Pazopanib formulation
US10966926B2 (en) 2010-04-14 2021-04-06 Vitux Group As Oral pharmaceutical dispersion compositions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011688A (en) * 1989-02-02 1991-04-30 Calam Henry D Liquid composition for the relief of premenstrual and menstrual discomforts
IT1256616B (en) * 1992-12-02 1995-12-12 Zambon Spa SYRUP CONTAINING N-ACETYL-CISTEIN
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
IL154307A0 (en) 2000-08-07 2003-09-17 Ranbaxy Signature Llc Liquid formulation of metformin
ITMI20020986A1 (en) * 2002-05-10 2003-11-10 Acraf COMPOSITION BASED ON DICLOFENAC FOR THE TOPICAL TREATMENT OF AFFECTIONS OF THE OROPHARINGOUS CABLE
JP2004059488A (en) * 2002-07-29 2004-02-26 Asahi Food & Healthcare Ltd Lactobacillus intestinal disorder controlling composition and food
JP2006315966A (en) * 2005-04-11 2006-11-24 Sanei Gen Ffi Inc Liquid composition for pharyngolarynx containing black soybean extract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
NL7607316A (en) * 1975-07-04 1977-01-06 Gaba Ag ORAL AND DENTAL CARE PRODUCTS.
CH655507B (en) * 1983-01-12 1986-04-30

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10966926B2 (en) 2010-04-14 2021-04-06 Vitux Group As Oral pharmaceutical dispersion compositions
US10080802B2 (en) 2011-10-31 2018-09-25 Novartis Ag Pazopanib formulation
US10596263B2 (en) 2011-10-31 2020-03-24 Novartis Ag Pazopanib formulation

Also Published As

Publication number Publication date
DK561589D0 (en) 1989-11-09
DK175752B1 (en) 2005-02-07
IL92190A0 (en) 1990-07-26
DK561589A (en) 1990-05-11
ES2054089T3 (en) 1994-08-01
KR0152983B1 (en) 1998-11-16
CA2002472C (en) 2000-05-30
ZA898554B (en) 1990-08-29
IE893611L (en) 1990-05-10
JPH02178224A (en) 1990-07-11
IE63482B1 (en) 1995-05-03
NZ231320A (en) 1992-11-25
KR910009253A (en) 1991-06-28
AU4434389A (en) 1990-06-07
GR3007995T3 (en) 1993-08-31
PT92228B (en) 1995-07-06
EP0373103B1 (en) 1993-03-31
DE58903964D1 (en) 1993-05-06
ATE87476T1 (en) 1993-04-15
JP2894744B2 (en) 1999-05-24
IL92190A (en) 1996-07-23
AU624190B2 (en) 1992-06-04
PT92228A (en) 1990-05-31
SA90100152B1 (en) 2001-04-14
EP0373103A1 (en) 1990-06-13

Similar Documents

Publication Publication Date Title
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
AU7405387A (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
ZA885192B (en) Pharmaceutical preparations
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
MX9704037A (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
AU1530088A (en) Conditioning liquids for tooth or bone matter
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
CA2002472A1 (en) Liquid oral formulation
AU1971988A (en) Pharmaceutical compositions for the treatment of uraemia
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
AU5917390A (en) Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
IL87490A0 (en) Pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for the treatment of alcoholism
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
AU7071487A (en) Chlorpheniramine therapy
IE870577L (en) Topical amide preparation
NO165542C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ARYL-2,4-DIALKYL-3H-1,2,4-TRIAZOL-3-THIONER.
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NO164100C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-CHLORO-S-TRIAZOLO- (4,3-A) -PYRIDINE-7-CARBOXYL ACIDS.
AU7907987A (en) Pharmaceutical composition for the treatment of high blood pressure

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry